» Articles » PMID: 36528068

Functions of the Aryl Hydrocarbon Receptor (AHR) Beyond the Canonical AHR/ARNT Signaling Pathway

Overview
Date 2022 Dec 17
PMID 36528068
Authors
Affiliations
Soon will be listed here.
Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor regulating adaptive and maladaptive responses toward exogenous and endogenous signals. Research from various biomedical disciplines has provided compelling evidence that the AHR is critically involved in the pathogenesis of a variety of diseases and disorders, including autoimmunity, inflammatory diseases, endocrine disruption, premature aging and cancer. Accordingly, AHR is considered an attractive target for the development of novel preventive and therapeutic measures. However, the ligand-based targeting of AHR is considerably complicated by the fact that the receptor does not always follow the beaten track, i.e. the canonical AHR/ARNT signaling pathway. Instead, AHR might team up with other transcription factors and signaling molecules to shape gene expression patterns and associated physiological or pathophysiological functions in a ligand-, cell- and micromilieu-dependent manner. Herein, we provide an overview about some of the most important non-canonical functions of AHR, including crosstalk with major signaling pathways involved in controlling cell fate and function, immune responses, adaptation to low oxygen levels and oxidative stress, ubiquitination and proteasomal degradation. Further research on these diverse and exciting yet often ambivalent facets of AHR biology is urgently needed in order to exploit the full potential of AHR modulation for disease prevention and treatment.

Citing Articles

Single-cell RNA sequencing revealed changes in the tumor microenvironment induced by radiotherapy for cervical cancer and the molecular mechanism of mast cells in immunosuppression.

Xue L, Gao L, Zhou S, Yan C, Zhang X, Lin W Funct Integr Genomics. 2025; 25(1):63.

PMID: 40082276 DOI: 10.1007/s10142-025-01564-7.


The Aryl Hydrocarbon Receptor (AHR): Peacekeeper of the Skin.

Dawe H, Di Meglio P Int J Mol Sci. 2025; 26(4).

PMID: 40004095 PMC: 11855870. DOI: 10.3390/ijms26041618.


Indole derivatives ameliorated the methamphetamine-induced depression and anxiety via aryl hydrocarbon receptor along "microbiota-brain" axis.

Wang X, Hu M, Wu W, Lou X, Gao R, Ma T Gut Microbes. 2025; 17(1):2470386.

PMID: 39996473 PMC: 11864316. DOI: 10.1080/19490976.2025.2470386.


Astaxanthin protects against environmentally persistent free radical-induced oxidative stress in well-differentiated respiratory epithelium.

Yamamoto A, Sly P, Khachatryan L, Begum N, Yeo A, Robinson P Redox Biol. 2025; 81:103542.

PMID: 39952200 PMC: 11875192. DOI: 10.1016/j.redox.2025.103542.


Structural basis for the ligand-dependent activation of heterodimeric AHR-ARNT complex.

Diao X, Shang Q, Guo M, Huang Y, Zhang M, Chen X Nat Commun. 2025; 16(1):1282.

PMID: 39900897 PMC: 11791172. DOI: 10.1038/s41467-025-56574-7.


References
1.
Dhakshinamoorthy S, Jaiswal A . c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene. 2002; 21(34):5301-12. DOI: 10.1038/sj.onc.1205642. View

2.
Lahoti T, Boyer J, Kusnadi A, Muku G, Murray I, Perdew G . Aryl Hydrocarbon Receptor Activation Synergistically Induces Lipopolysaccharide-Mediated Expression of Proinflammatory Chemokine (c-c motif) Ligand 20. Toxicol Sci. 2015; 148(1):229-40. PMC: 4731409. DOI: 10.1093/toxsci/kfv178. View

3.
Borland M, Krishnan P, Lee C, Albrecht P, Shan W, Bility M . Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes. Carcinogenesis. 2014; 35(7):1602-12. PMC: 4076811. DOI: 10.1093/carcin/bgu067. View

4.
Mohammadi-Bardbori A, Vikstrom Bergander L, Rannug U, Rannug A . NADPH Oxidase-Dependent Mechanism Explains How Arsenic and Other Oxidants Can Activate Aryl Hydrocarbon Receptor Signaling. Chem Res Toxicol. 2015; 28(12):2278-86. DOI: 10.1021/acs.chemrestox.5b00415. View

5.
Boverhof D, Burgoon L, Williams K, Zacharewski T . Inhibition of estrogen-mediated uterine gene expression responses by dioxin. Mol Pharmacol. 2007; 73(1):82-93. DOI: 10.1124/mol.107.040451. View